baber/WOPTO huggingface dataset:
Patent AU-714128-B2 (AU)
Title: Method for making a skip body with a concave cross section
Inventor: DECKERT SERGE
IPC: B21D5/00
Filed: 1997-02-27
Granted: 1999-12-16
Abstract: A method for forming a one-piece skip body with a concave cross section from a large metal sheet (1) by imparting an approximate cross section to the sheet using shaping mechanisms (2) is disclosed. According to the method, the approximate cross section is maintained while a sealing plate (10) is secured to one end (9) and a stiffening reinforcement member (13) shaped according to the final cross section is attached to the other end (12). The longitudinal edges are stiffened then the most curved areas are mechanically treated and the shaping mechanisms (2) are released. The method is relevant to skip manufacturers and more generally to builders of utility vehicles.
Patent AU-572476-B2 (AU)
Title: Differential gain/phase compensation for multi-head v.t.r.
Inventor: YOSHINAKA TADAAKI
IPC: H04N5/95
Filed: 1983-11-14
Granted: 1988-05-12
Abstract: A method for recording a video signal having luminance and chrominance signals by using a plurality of rotary transducing heads on a recording tape moved longitudinally by a drive mechanism, in which the time axis of the video signal is extended as long as N times, the time axis expanded video signal is divided to N channels, and first and second pilot signals have a predetermined frequency are alternately inserted into a predetermined position of a horizontal blanking period of the devided video signal. In this case, the DC voltage level of the first and second pilot signals are selected near the white peak level and near the black level respectively.` An apparatus for recording a video signal having luminance and chrominance signals on a recording tape is also disclosed which includes a circuit for expanding the time axis of the video signal, a divider for dividing the expanded video signal into a plurality of channel video signals, a circuit for producing first and second pilot signals having a predetermined frequency and DC voltage level, the DC voltage level of the first and second pilot signals being different each other and an adding circuit for adding said first and second pilot signals alternately in the horizontal blanking period of the plurality of channel video signals respectively.
Patent AU-637954-B2 (AU)
Title: Body support system
IPC: G05D16/06
Filed: 1992-09-09
Granted: 1993-06-10
Abstract: An air bed (10) comprising an air mattress (25) having a plurality of interconnected rows and columns of air cells (35) divided into longitudinally isolated zones (41-45), and an airflow control system (15) for supplying air at differing pressures to the zones such that a person reclining atop the mattress is supported and maintained in spinal alignment at subischemic applied pressures.
Patent AU-566469-B2 (AU)
Title: Tube pressure filter
Inventor: WALL GEORGE WILSON
IPC: B01D25/12
Filed: 1984-02-03
Granted: 1987-10-22
Abstract: The inner assembly (2) of a tube pressure filter comprises a core (6) provided with a facing (36) made up of a plurality of laths. At the end of the core (6) there is an annular member (42, 44) which is retained in position between the facing (36) and a split retaining ring (60, 62). The retaining ring (60, 62) fits in a groove (58) in the core and is locked in position by locking elements (64) which fit into aligned recesses in the retaining ring (60, 62) and the annular member (42, 44) and are secured by screws (68).
Patent AU-575040-B2 (AU)
Title: Epsilon-caprolactone modified acrylic polymers
Inventor: ETZELL ROGER A
IPC: C08L33/00
Filed: 1984-02-28
Granted: 1988-07-21
Abstract: Flexible coatings are applied to the outer surfaces of automotive vehicles having metal and plastic portions from coating compositions having about 40 to 95 % by weight of an epsilon-caprolactone modified acrylic polymer and about 5 to 45% by weight of an aminoplast resin cross-linking agent, the epsilon-caprolactone modified acrylic polymer having a number average molecular weight of about 1,000 to 6,000, hydroxyl contents from about 1 to 7% by weight, optionally about 0.1 to 4.0% by weight carboxyl contents and about 0.25 to 6 moles epsilon-caprolactone per mole of hydroxyl and or carboxyl in the polymer, the coating composition having a solids content of about 35 to 68% by weight and a liquid carrier of about 32 to 65% by weight.
Patent AU-742920-B2 (AU)
Title: Autoclavable pharmaceutical compositions containing a chelating agent
Inventor: KIS GYORGY LAJOS
IPC: A61K9/08
Filed: 1999-01-13
Granted: 2002-01-17
Abstract: The present invention describes an autoclavable ophthalmic composition comprising ketotifen.
Patent AU-695305-B2 (AU)
Title: Data transmission method, base station, and subscriber terminal
Inventor: GLISIC SAVO
IPC: H04J13/00
Filed: 1995-06-19
Granted: 1998-08-13
Abstract: PCT No. PCT/FI95/00350 Sec. 371 Date Apr. 19, 1996 Sec. 102(e) Date Apr. 19, 1996 PCT Filed Jun. 19, 1995 PCT Pub. No. WO95/35637 PCT Pub. Date Dec. 28, 1995A base station, subscriber terminal, and data transmission method in a CDMA cellular radio network having in each cell at least one base station which communicates on a specified traffic channel with the terminal equipments (Mobile Station) located within its area, the signal of the users being divided in the method into bursts in the time domain. To achieve high traffic capacity together with high-quality connections, the base station monitors the load state of the traffic channel in the data transmission method of the invention and transmits information about the load state of the traffic channel to the terminal equipments. In the method, the number of the bursts transmitted between the terminal equipments and the base stations per time unit is controlled on the basis of the delay state of the bursts and the load state information computed at the base station.
Patent AU-767163-B2 (AU)
Title: Methods for restoring and/or enhancing accommodation in pseudo phakia
Inventor: GWON ARLENE
IPC: A61K31/341
Filed: 2000-01-25
Granted: 2003-10-30
Abstract: A method for increasing the amount of accommodation in an eye of a mammal which eye includes an artificial intraocular lens. The method provides for administering to the mammal the amount of a muscarinic agent necessary to restore tonic accommodation.
Patent AU-708853-B2 (AU)
Title: Adjusting cooling air in glass tempering machine
Inventor: VEHMAS JUKKA
IPC: C03B27/044
Filed: 1997-05-21
Granted: 1999-08-12
Abstract: A method and an equipment for adjusting the cooling air of a glass tempering machine. Cooling air is led by at least one fan (1, 2) to a tempering area (4) for cooling the glass exiting a tempering furnace (11). By means of a closing device (10) the tempering area (4) can be reduced such that a tempering zone with a pressure that can be raised sufficiently high for tempering thin glass can be formed out of the reduced tempering area. In this manner the tempering result becomes very even, and no separate tempering zone is needed even for thin glass.
Patent AU-742137-B2 (AU)
Title: Articulated arm for transferring fluid products with U-shaped spring balancing
Inventor: STEPHANT JACQUES
IPC: B67D7/04
Filed: 1999-03-26
Granted: 2001-12-20
Abstract: The invention concerns an articulated arm for transferring fluid products comprising two tubular sections (7, 8+2) mutually linked by a pivoted connection (3) with horizontal axis, and a balancing device (4, 10) linked with each of the tubular sections to compensate torque variations about the pivoted connection axis while the two sections are rotating relatively. The invention is characterised in that the balancing device comprises a U-shaped spring (10) with two branches (11, 12) whereof the ends (11A, 12A) are each connected to a respective section.
Patent AU-613161-B2 (AU)
Title: Composition inducing a binding
Inventor: HAMMARSTROM LARS
IPC: A61K6/00
Filed: 1989-03-16
Granted: 1991-07-25
Abstract: Binding is induced between living mineralised tissue parts by applying a precursor to dental enamel (i.e. enamel matrix) which causes regeneration of the mineralised tissue on at least one of these parts. The enamel matrix can be obtained from pigs or cattle and is combined with a carrier, diluent or adhesive. The enamel matrix can also be obtained by recombinant DNA techniques or cultivation of diploid cells.
Patent AU-712770-B2 (AU)
Title: Chewing gums containing dipeptide sweetener
Inventor: FRY JOHN CHARLES
IPC: A23L27/30
Filed: 1997-07-14
Granted: 1999-11-18
Abstract: The invention relates to chewing gums containing dipeptide sweetener, both in a sugar-free and in a sugar-containing form, and other chewable products. Improved flavor, in terms of both quality and persistence, in particular in the case of products which also contain flavorings based on aldehydes, is achieved when the dipeptide sweetener is a sweetening salt of an aspartic-acid-derived dipeptide sweetener and a derivative of a sweetening acid. The particle size of the sweetening salt is preferably smaller than 200 mum, and the sweetening salt is preferably present in a quantity from 100 to 6000 ppm.The invention also relates to processes for production of such chewing gums.
Patent AU-762717-B2 (AU)
Title: Anti-inflammatory, antibacterial benzyl phenol agents
Inventor: BRAHMS JOHN C
IPC: A61K8/33
Filed: 1999-04-07
Granted: 2003-07-03
Abstract: An antibacterial, anti-inflammatory compound for use in oral products, of the formulae: Wherein: R1 and R2 are straight chain or branched alkyl substituents or cycloalkyls with one or more alkyl substituents.
Patent AU-772120-B2 (AU)
Title: Smoke detector housing
Inventor: RUTTER NICHOLAS ALEXANDER
IPC: G08B21/14
Filed: 2000-03-27
Granted: 2004-04-08
Abstract: Provided is an alarm for detecting heat, radiation and/or pollutants. The alarm includes housing means and also includes detection means for detecting the heat, radiation and/or pollutants. The detection means, in turn, includes detection circuitry and a power source, and is contained within a cartridge that is mountable within the housing means and removable therefrom.
Patent AU-666171-B2 (AU)
Title: Disposable inhaler II
Inventor: KALLSTRAND GORAN
IPC: A61M13/00
Filed: 1993-03-03
Granted: 1996-02-01
Abstract: The invention relates to a disposable breath-actuated inhaler comprising a tubular housing forming an air flow path being open at both ends, one end forming an air inlet (4) and one end forming an air outlet (5), said housing comprising a compartment (3) for storing a pharmaceutical powder to be inhaled. The compartment (3) for storing the pharmaceutical powder is located close to the air inlet (4) and is covered by a thin foil (6) sealing the compartment in an airtight way which can be removed from the compartment from outside the housing, said housing being shaped with a constriction (9) adjacent the powder compartment (3) such that a turbulent air stream will be obtained at the constriction upon inhalation which will lift the powder out from the compartment (3) and mix the powder into the air stream. <IMAGE>
Patent AU-572916-B2 (AU)
Title: Cephalosporin derivatives
Inventor: ANGERBAUER ROLF
IPC: C07D501/18
Filed: 1984-11-16
Granted: 1988-05-19
Abstract: Antibacterially effective cephalosporins of the formula   <IMAGE> in which R1 denotes C1-C6-alkyl, phenyl or halogen-substituted phenyl and A represents a nitrogen-containing, positively charged heterocyclic 5-membered to 7-membered ring which is bonded via N and can contain a total of up to 4 hetero-atoms from the group comprising N, O and S, and onto which up to two further rings can be fused, and which can optionally be substituted, with the proviso that, if the ring is a 6-membered ring, A does not represent an unsubstituted pyridine ring or a pyridine ring which is mono- or di-substituted by identical or different substituents from the group comprising C1-C4-alkyl, chlorine, bromine, carbamoyl or N-C1-C4-alkylcarbamoyl, or pharmaceutically acceptable salts thereof or esters thereof which can be split under physiological conditions.
Patent AU-629836-B2 (AU)
Title: Rare earth trifluoride with new morphological characteristics and the process for obtaining it
Inventor: DISSAUX ANTOINE
IPC: C01F17/265
Filed: 1989-06-28
Granted: 1992-10-15
Abstract: The present invention relates to a rare-earth trifluoride with new morphological characteristics. 
<??>It also relates to the process for obtaining the said fluoride, which is characterised in that an aqueous solution of a rare-earth salt is reacted with a solution of ammonium fluoride, the precipitate formed is separated off and is subjected to a heat treatment. 
<??>The rare-earth fluoride of the invention has a fine and monodisperse particle size distribution.
Patent AU-675783-B2 (AU)
Title: Reaction-based selection for expression of and concentrationof catalytic moieties
Inventor: BLACKBURN GARY F
IPC: C12N15/10
Filed: 1993-02-24
Granted: 1997-02-20
Abstract: A recombinant virus or an organism population capable of expression of a surface-bound catalytic moiety is selected by:-  reaction-based selection for catalytic activity by a surface-bound catalytic moiety of a population of recombinant viruses or organisms expressing the catalytic moiety, and isolating from said population a subpopulation which can act catalytically,  wherein the reaction-based selection comprises contacting said population with a surface including an immobilized hapten or substrate and eluting from said surface said subpopulation which can act catalytically while retaining a population that has binding affinity for the hapten or substrate but no catalytic activity. The method can be used to increase the proportion of catalytic to non-catalytic moieties in a sample. Also provided is a method for producing a recombinant virus or cell line, capable of expression of a surface-bound catalytic moiety and a substantially pure recombinant virus population or cell line. <IMAGE>
Patent AU-765030-B2 (AU)
Title: Pyrazole derivatives as p-38 map kinase inhibitors
Inventor: LABADIE SHARADA SHENVI
IPC: A61K31/4427
Filed: 1999-04-28
Granted: 2003-09-04
Abstract: The present invention relates to certain pyrazole derivatives of Formula (I) that are p-38 MAP kinase inhibitors, pharmaceutical compositions containing them, methods for their use, and methods for preparing these compounds.
Patent AU-726673-B2 (AU)
Title: Method of manufacturing ejector pin sleeves
Inventor: LAWRENCE DAVID E
IPC: C21D9/08
Filed: 1997-09-05
Granted: 2000-11-16
Abstract: A method is disclosed for manufacturing ejector sleeves from tubular stock. In particular, the method includes the following steps or operations: (a) cutting the tube stock to length, (b) enlarging a portion of the inside diameter of the sleeve to provide a clearance diameter, (c) rough-sizing a close-fitting inner diameter, (d) optionally semi-finishing the outside diameter of the sleeve, (e) hardening and straightening the sleeve, (f) final sizing of the outside diameter while maintaining concentricity with the inside diameters, (g) finishing the end face of the sleeve adjacent the close-fitting diameter, (h) final sizing of the close-fitting inner diameter while maintaining concentricity with the outside diameter, (i) forming a head on the sleeve by heating and forging to a predetermined size, (j) optional annealing and refinishing of the head for purposes of hardness or dimensional modification, or improving surface finish.
Patent AU-784932-B2 (AU)
Title: Medical needle assemblies
Inventor: SWENSON JON D
IPC: A61M5/00
Filed: 2002-05-21
Granted: 2006-08-03
Abstract: A shielded, sterile, single-use unit dose needle assembly includes a unit dose needle (40) with a hub (60) and two packaging shields sealingly mated to one another encasing the hub (60) and unit dose needle (40). The unit dose needle (40) has a handle end (42) and a patient end (44) configured to hold a unit dose of a vaccine. The hub (60) is fixedly attached to the unit dose needle (40) between the handle end (42) and the patient end (44). The first packaging (100) shield extends over the patient end, and the second packaging (120) shield extends over the handle end (42) of the unit dose needle. The fist (100) and second packaging (120) shields are removably attached to one another to form an air-tight sterility seal, with the unit dose needle (40) contained within the first packaging shield (100). <IMAGE>
Patent AU-576601-B2 (AU)
Title: Hydrates of fluoral and of hexafluoroacetone from hemiacetals
Inventor: CHEMINAL BERNARD
IPC: C07C31/38
Filed: 1985-07-16
Granted: 1988-09-01
Abstract: A process for preparing pure fluoral hydrate or hexafluoroacetone hydrate which comprises reacting a hemiacetal with the formula <IMAGE>   wherein R is hydrogen or CF3, with water in a distillation column, removing respectively the methanol or ethanol produced at the head of the column, and recovering at the bottom of the column the pure hydrate so produced.
Patent AU-723434-B2 (AU)
Title: Low density, light weight intumescent coating
Inventor: HANAFIN JOSEPH W
IPC: C09D163/00
Filed: 1997-09-23
Granted: 2000-08-24
Abstract: A low density, epoxy-based intumescent fire resistive coating, having a density below about 1.10 grams/cc, and most preferably below about 1.0 grams/cc, and a method for forming the same, are disclosed. This method includes the steps of forming an epoxy-based intumescent mastic, having minute particles of amorphous silica dispersed therein. The mastic is then sprayed in droplets on at least one surface of a substrate to form a low density mastic coating on the surface. The low density mastic coating then cures to form a low density, intumescent fire resistive coating. Preferably, the method of invention further includes the step of dispersing at least one type of gas within the mastic, or within at least one part of the mastic to further reduce the density of the cured intumescent coating.
Patent AU-706095-B2 (AU)
Title: Imidazole derivative
Inventor: SUGIMOTO HIROHIKO
IPC: C07D401/04
Filed: 1995-09-25
Granted: 1999-06-10
Abstract: An imidazole derivative represented by general formula (I) or a salt thereof, having the effect of specifically inhibiting the growth of HIV as a pathogenic virus and being reduced in toxicity. In said formula R<1> represents hydrogen, C1-C20 alkyl, C2-C7 alkenyl, C4-C12 cycloalkylalkyl, etc.; R<2> represents C1-C6 alkyl, C1-C6 acyl, hydroxyiminomethyl, hydrazonomethyl or -(CH2)n-R<4> (R<4> being halogeno, alkoxy, hydroxy, etc.; and n being an integer of 1 to 3); R<3> represents substituted or unsubstituted C1-C6 alkyl; X and Y represent each independently hydrogen, C1-C3 alkyl, halogeno, or nitro; and Z represents S, SO, SO2 or CH2. <CHEM>
Patent AU-658536-B2 (AU)
Title: Sheeting device
Inventor: HESS WILHELM
IPC: E02D17/08
Filed: 1993-09-04
Granted: 1995-04-13
Abstract: An apparatus for sheeting a deep trench, including pairs of vertical support rails arranged along the trench so that the support rails of each pair of support rails are opposite each other at an equal distance, the support rails having guide channels, a rigid strut frame holding the support rails of a pair of rails at a distance from each other and being formlockingly displaceable on the support rails, and large-surfaced outer sheeting plates and inner sheeting plates having vertical edges that are vertically displaceable in the guide channels of the support rails, the support rails having two side walls spaced from each other which, together with an outer wall and an inner wall, form an at least partially closed box beam, and the guide channels being formed, at least partially, on outer sides of the side walls by guide flanges, which lay in the plane of the outer wall, and support flanges which are spaced from the guide flanges, the side walls of the support rails being extended inward past the inner wall, the support flanges being provided on projecting end portions of the side walls, a vertical guide channel being provided between the support flanges and projecting portions of the side walls, which vertical guide channel formlockingly encompasses a rail located at a respected end of the strut frame, the strut frame being provided on opposite sides of the rail with rollers rotatably supported on a horizontal axle and adapted to roll on outer sides of the support flanges.
Patent AU-733674-B2 (AU)
Title: Vascular endothelial growth factor (VEGF) nucleic acid ligand complexes
Inventor: JANJIC NEBOJSA
IPC: A61P35/00
Filed: 1997-10-17
Granted: 2001-05-24
Abstract: This invention discloses a method for preparing a complex comprised of a VEGF Nucleic Acid Ligand and a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound by identifying a VEGF Nucleic Acid Ligand by SELEX methodology and associating the VEGF Nucleic Acid Ligand with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further discloses Complexes comprising one or more VEGF Nucleic Acid Ligands in association with a Non-Immunogenic, High Molecular Weight Compound or Lipophilic Compound. The invention further includes a Lipid construct comprising a VEGF Nucleic Acid Ligand or Complex and methods for making the same.
Patent AU-600658-B2 (AU)
Title: Molecularly cloned acquired immunodeficiency syndrome polypeptides and their methods of use
Inventor: CAPON DANIEL JEFFREY
IPC: C07K14/245
Filed: 1985-12-23
Granted: 1990-08-23
Abstract: Diagnostic product and vaccine for Acquired Immuno-deficiency Syndrome AIDS) and methods for making and using same, wherein viral polypeptide sequences from an AIDS associated retrovirus are expressed directly or as a fusion polypeptide in a prokaryotic or mammalian cell expression host to produce a diagnostic product which specifically binds complementary antibody produced by individuals afflicted with AIDS or a vaccine against AIDS which confers resistance to infection by AIDS associated retrovirus. The reverse transcriptase of an AIDS associated retrovirus is used separately or in a whole cell assay to identify compounds which selectively inhibit retroviral reverse transcriptase.
Patent AU-776508-B2 (AU)
Title: Virulence genes, proteins, and their use
Inventor: TANG CHRISTOPH
IPC: A61P31/04
Filed: 2001-05-08
Granted: 2004-09-09
Abstract: A series of genes from  Neisseria meningitidis  are shown to encode products which are implicated in virulence. The identification of these genes therefore allows attenuated microorganisms to be produced. Furthermore, the genes or their encoded products can be used in the manufacture of vaccines for therapeutic application.
Patent AU-663237-B2 (AU)
Title: A multi-sheet glazing unit
Inventor: LEOPOLD EDMUND A
IPC: B29C48/05
Filed: 1994-01-14
Granted: 1995-09-28
Abstract: A nozzle (104) for depositing the shaped layer of the piable material includes a platform (110) having a shaping tip (114). The shaping tip has converging sides at one end (116) and generally parallel sides at the other end (118). The portion of the tip at the first end (116) has a lower elevation than the portion of the tip at the second end (118). Holes (124,126) for moving the pliable material are provided in the platform (110) on each side of the tip (114) and in tips intermediate its ends. The different elevation and converging end (116) minimizes if not eliminates tailing. <IMAGE>
Patent AU-618469-B2 (AU)
Title: Deactivation of phosphonium biocides
Inventor: COOPER KENNETH GRAHAM
IPC: C02F1/58
Filed: 1990-04-17
Granted: 1991-12-19
Abstract: Solutions of organophosphorus biocides which also contain dissolved oxygen are deactivated by adding a catalytic amount of activated carbon.
Patent AU-761513-B2 (AU)
Title: Method for vacuum deposit on a curved substrate
Inventor: COMBLE PASCAL
IPC: C23C14/24
Filed: 1999-09-02
Granted: 2003-06-05
Abstract: The invention concerns a method which consists in a process known per se in producing, on the curved substrate ( 10 ) to be treated, a film of material derived from a specific material source ( 13 ). The invention is characterized in that it consists in inserting, between the curved substrate ( 10 ) and the material source ( 13 ), a mask ( 19 ) relative to the curved substrate ( 10 ), preferably selecting as mask ( 19 ), a mask comprising a ring-shaped part ( 20 ). The invention is particularly useful for providing lenses with antiglare treatment.